000 01432 a2200397 4500
005 20250514004420.0
264 0 _c20010920
008 200109s 0 0 ita d
022 _a0034-1193
040 _aNLM
_beng
_cNLM
100 1 _aModlin, I M
245 0 0 _a[Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma].
_h[electronic resource]
260 _bRecenti progressi in medicina
_c
300 _a456-61 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
650 0 4 _a2-Pyridinylmethylsulfinylbenzimidazoles
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Ulcer Agents
_xadministration & dosage
650 0 4 _aBenzimidazoles
_xadministration & dosage
650 0 4 _aEnzyme Inhibitors
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aGastric Acid
_xmetabolism
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Endocrine Neoplasia Type 1
_xdrug therapy
650 0 4 _aOmeprazole
_xanalogs & derivatives
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aPantoprazole
650 0 4 _aSulfoxides
_xadministration & dosage
650 0 4 _aTime Factors
650 0 4 _aZollinger-Ellison Syndrome
_xdrug therapy
773 0 _tRecenti progressi in medicina
_gvol. 92
_gno. 7-8
_gp. 456-61
999 _c11403115
_d11403115